| Pharmaceutical active ingredients: |
| Daunorubicin Hydrochloride |
| Available forms, composition and doses of Daunoblastina: |
| Injectable; Injection; Daunorubicin Hydrochloride 20 mg |
| Daunoblastina medical category: |
| Human:Antineoplastic agentsCytotoxic chemotherapy |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| L01DB02 - Daunorubicin |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| PfizerKenfarmaZuellig Pharma |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Rubomycin C | Daunorubicin | Unidentified Pharmaceutical Company |
| DaunoXome | Daunorubicin Citrate | Gilead; Calea Austria Healthcare; Fresenius; NeXstar Pharmaceuticals; Orphan Pharmaceutical; United Medical, Brazil |
| Cerubidin | Daunorubicin Hydrochloride | Sanofi-Aventis |
| Cerubidine | Daunorubicin Hydrochloride | Sanofi-Aventis; Bedford Laboratories; ERFA; Thissen Laboratoires; Wyeth |
| Daunoblastin | Daunorubicin Hydrochloride | Pfizer |
| Daunocin | Daunorubicin Hydrochloride | Meizler; Korea United; Kyowa Hakko; Miracalus Pharma |
| Daunoplus | Daunorubicin Hydrochloride | VHB Lifesciences |
| Daunorubicin | Daunorubicin Hydrochloride | Bedford Laboratories |
| Daunorubicin | Daunorubicin Hydrochloride | Bigmar Bioren Pharmaceuticals |
| Daunorubicin | Daunorubicin Hydrochloride | Lans-Pharm |